About us
Research Library
Company Pages
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us
More Company News
Allergy Therapeutics
Data at WAO-BSACI
25 Apr 2022
Read More
Allergy Therapeutics
H122 interim results
03 Mar 2022
Read More
Allergy Therapeutics
New data at AAAAI 2022 meeting
01 Mar 2022
Read More
Allergy Therapeutics
New credit facility secured
02 Feb 2022
Read More
Allergy Therapeutics
FDA clearance of IND application for VLP Peanut
26 Jan 2022
Read More
Allergy Therapeutics
H122 trading update & notice of results
13 Jan 2022
Read More
Allergy Therapeutics
Positive top line results from G309 exploratory field trial
25 Oct 2021
Read More
Allergy Therapeutics
Preliminary FY21 results
23 Sep 2021
Read More
Allergy Therapeutics
Secondary endpoints from VLP Peanut 001
13 Sep 2021
Read More
Allergy Therapeutics
Successful primary outcome of VLP Peanut 001
03 Aug 2021
Read More
1
2
3
Return to Allergy Therapeutics
© 2019-22 Trinity Delta. All rights reserved. Trinity Delta is regulated by the Financial Conduct Authority (Reference number: 725161).
About us
Research Library
Company Pages
▼
Allergy Therapeutics
ANGLE
Arecor Therapeutics
Avacta
Futura Medical
HUTCHMED
MaxCyte
Nexstim
Redx Pharma
Scancell
Contact us